Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04855110Unknown
Randomised, open-label trial of warfarin (2 arms), sponsored by Cairo University. Primary endpoints: Occurrence of subcutaneous and / or sub-rectus hematoma at 14 days, Occurrence of intra-abdominal bleeding at 14 days and 4 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04855110.